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NEWS AND VIEWS
The most important questions in cancer 
research and clinical oncology
Question 1. Could the vertical transmission of human papilloma virus (HPV) infection 
account for the cause, characteristics, and epidemiology of HPV-positive oropharyngeal 
carcinoma, non-smoking East Asian female lung adenocarcinoma, and/or East Asian 
triple-negative breast carcinoma?
Joseph T. S. Wee1,2* and Sharon Shuxian Poh1
Abstract 
Specific research foci: (1) Mouse models of gamma-herpes virus-68 (γHV-68) and polyomavirus (PyV) infections during 
neonatal versus adult life. (2) For human papilloma virus (HPV)-positive oropharyngeal carcinoma (OPC)—(a) Ask-
ing the question: Is oral sex a powerful carcinogen? (b) Examining the evidence for the vertical transmission of HPV 
infection. (c) Examining the relationship between HPV and Epstein–Barr virus (EBV) infections and nasopharyngeal 
cancer (NPC) in West European, East European, and East Asian countries. (d) Examining the association between HPV-
positive OPC and human leukocyte antigen (HLA). (3) For non-smoking East Asian female lung adenocarcinoma—(a) 
Examining the incidence trends of HPV-positive OPC and female lung adenocarcinoma according to birth cohorts. 
(b) Examining the association between female lung adenocarcinoma and HPV. (c) Examining the associations of lung 
adenocarcinoma with immune modulating factors. (4) For triple-negative breast carcinoma (TNBC) in East Asians—
(a) Examining the association between TNBC and HPV. (b) Examining the unique epidemiological characteristics of 
patients with TNBC. A summary “epidemiological” model tying some of these findings together.
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Mouse model
Mice infected with different viruses during neonatal or 
adult life display different outcomes.
For PyV infection, Rowe et  al. [1] first reported that 
“only infection of new-born mice resulted in persistently 
infected mice that were subsequently able to transmit 
PyV infection to other mice, whereas mice infected as 
adults were unable to transmit PyV infections or establish 
persistent infections.” Immunocompetent adult mice do 
not appear to be affected by PyV infection. Demengeot 
et al. [2] showed that infection is persistent in some epi-
thelial tissues (the skin, mammary and salivary glands), 
lymphoid organs (the spleen and nodes), and mesenchy-
mal bone tissue.
For γHV-68 infection, Ptaschinski and Rochford [3] 
observed that unlike infection of adult mice, infection of 
8-day-old pup mice with γHV-68 results in disseminated 
acute infection, delayed clearance and persistence of the 
virus in the lungs, and no significant infectious mononu-
cleosis-like syndrome.
Ptaschinski and Rochford [3] also noted that infection 
with other viruses, such as the respiratory syncytial virus, 
hepatitis viruses, and cytomegalovirus, at a young age are 
all associated with chronic infection, and this may be “due 
to differences in the infant and adult immune systems.” In 
hepatitis occurring in woodchucks, chronic persistence 
may be “due in part to a decrease in the T cell response 
along with a decrease in Th1-associated cytokines.” Simi-
larly, children infected with cytomegalovirus exhibit a 
decreased interferon-γ production and decreased CD4+ 
T-cell response.
Ptaschinski and Rochford [3] further commented that 
while most children in developing countries are infected 
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with EBV by the age of 1, most studies on EBV pathogen-
esis rely on cells isolated from either asymptomatic adults 
or adults with infectious mononucleosis. Burkitt’s lympho-
mas occur primarily in childhood and usually present in 
the jaw area, and it has been hypothesized that early EBV 
infection is a risk factor. Ptaschinski and Rochford [3] men-
tioned that “whether early age of infection leads to higher 
viral persistence in mucosal sites in children remains to be 
determined” and potentially “γHV-68 infection of young 
mice can be used as a model to study age-dependent per-
sistence of γHV-68 infection at mucosal sites.”
Toll-like receptor 8 (TLR8) is involved in the innate 
immune response to different pathogens. In mice, TLR8 
lacks five amino acids and is non-functional and perhaps 
redundant, but it plays a critical role in humans as it is the 
only TLR that is active in the neonatal period as described 
by Levy and Zarember [4]. Cheng et al. [5] showed that the 
allele frequencies of TLR8 in East Asians significantly dif-
fered from those in African–Americans and Caucasians 
and that it may be an important factor in the disparity of 
viral infections amongst different ethnic groups. Barreiro 
et al. [6] further showed that the “human TLR8 is the TLR 
under the strongest purifying selection.”
HPV‑positive OPC
Is oral sex a powerful carcinogen?
Genden et al. [7] wrote that although HPV-positive oro-
pharyngeal squamous cell cancer has been linked to sex-
ual practices and increasing numbers of sexual partners, 
it is also present in many individuals reporting few sexual 
partners. Only a small percentage of individuals have a 
high number of partners, and a small number of sexual 
partners do not lower the risk. Moreover, HPV-positive 
oropharyngeal squamous cell cancer appears to affect 
men more than women.
In a provocative article, Rosenquist [8] summarized 
the data for cervical cancer and noted that the majority 
of HPV-infected women were able to clear their cervico-
vaginal infections spontaneously, leaving only a small 
percentage subsequently developing cervical cancer; thus 
making HPV infection a necessary, but not the sole fac-
tor, in the development of cervical cancer. She further 
highlighted several studies that showed that cervico-vag-
inal HPV infection is predominantly self-limiting with a 
median duration of 8–12 months. In large epidemiologi-
cal studies, “the risk factors most consistently associated 
with progression of high-risk HPV to cervical cancer 
were as follows: high parity (number of children), long-
term oral contraceptive use, smoking, and co-infection 
with other sexually transmitted diseases” [8].
In a longitudinal prospective Finnish family HPV infec-
tion study [9] highlighted by Rosenquist to question the 
role of oral sex in HPV infection transmission, couples 
were tested at both oral and genital sites over several 
occasions. It was found that “the oral and genital HPV 
types found in couples differ so that the strains infect-
ing one partner are only modestly correlated with strains 
infecting the other, with the prevalence of oral high-risk 
HPV infections fluctuating between 15% and 27%. Oral 
and genital HPV strains were not only poorly correlated 
within subjects but also highly discordant within couples. 
12% of women and 26% of men reported regular oral sex. 
However, oral sex habits showed no association with oral 
or genital HPV infection. Similarly, no association was 
established between oral HPV infections in either spouse 
and the outcome of the partner’s genital HPV infection.” 
Conversely, the researchers noted that “a persistent oral 
HPV infection of the spouse increased the risk of persis-
tent oral HPV infection tenfold in the other spouse” [9]. 
Also notable was that men tended to begin and com-
plete clearance of HPV infections earlier than women. 
This study thus implies the importance of persistent oral 
infection over the mere presence of infection or the prac-
tice of oral sex in contributing to the correlation of HPV 
within a couple.
A literature review on the sexual transmission of virus 
infections by Edwards and Carne [10] in 1998 concluded 
that “the evidence favouring oral transmission of HPV is 
both based on case studies, and is only correlational evi-
dence.” Rosenquist [8] further highlights a large survey 
(n  =  12,571) done in 2002 by the United States Cent-
ers for Disease Control and Prevention, showing that 
cunnilingus was practiced by 90% of male respondents 
and fellatio by 88% of female respondents. “Similarly, 
research from other cultures shows oral sexual contact to 
be very common, and oral genital contact is more com-
mon than anal intercourse among gay and bisexual men.” 
Thus, the “link between oral sex, HPV and cancer is not 
a simple cause and effect relationship,” especially as oral 
sex behaviors appear to be common and widespread, 
thus making any perceived relationship not significant. 
This led Rosenquist to conclude that many factors are 
involved in making an HPV infection to become persis-
tent, and subsequently, to become carcinogenic; some are 
unknown, and others are likely involved in compromises 
to the immune system.
In a meta-analysis, Li et  al. [11] demonstrated that 
“oral sex is only a risk marker rather than an independ-
ent risk factor for oral cancer.” On the other hand, Zeng 
et al. [12, 13] demonstrated that both tooth loss and peri-
odontal disease are independent risk factors for head and 
neck cancers. Similarly, Tezal et al. [14] reported that the 
tumor HPV infection status of patients with head and 
neck cancers may be associated with a history of chronic 
inflammatory disease in the oral cavity, with this associa-
tion being the strongest amongst OPC patients.
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One might be tempted to hypothesize that having mul-
tiple sexual partners might be an indicator for chronic 
infection and inflammation associated with sexual trans-
mission of HPV and other virus infections, which might 
have the same effect as chronic periodontitis perhaps 
through the systemic bystander effects of the immune 
system reacting to chronic infection and inflammation.
Evidence for the vertical transmission of HPV infection
In a review article, Mammas et al. [15] stated that “HPV 
can be transmitted through physical contact, as well as 
vertically from the HPV-positive mother to her new-
born and can cause subclinical or clinical infections. 
HPV-associated clinical infections include genital warts, 
skin warts, recurrent respiratory papillomatosis, squa-
mous intraepithelial lesions and cervical cancer.” A recent 
review by Syrjänen [16] suggests that vertical transmis-
sion of HPV infection occurs in approximately 20% of 
cases. HPV infections in the oral mucosa of infants are 
silent infections and are found in approximately 10% of 
infants. According to the review by Syrjanen [16], the 
concordance of HPV infections in the oral and genital 
specimens of mothers and their new-borns ranges from 
0.2% to 73%. The true impact of the silent infection of 
HPVs in childhood remains to be further investigated. 
On the other hand, the viral loads for persistent infection 
may be low and escape current detection techniques [17]. 
In similar light, it has been difficult to identify persistent 
EBV infection in epithelial cells; however, circumstantial 
evidence points toward early infection. In addition, a few 
studies isolated the EBV genome from the parotid gland 
as well as the virus from the ducts and orifices of the 
parotid glands [18].
Relationship between HPV and EBV
Several studies suggest that EBV and HPV infections do 
not co-exist in NPC patients in West and East European 
countries [19, 20].
Early EBV infection appears to be related to socio-eco-
nomic status and demonstrates a decreasing trend from 
East Asia through East to West Europe. On the other 
hand, the incidence trend of adolescent EBV infection in 
the form of infectious mononucleosis is reversed, and this 
effect is also reflected by the incidence of multiple sclero-
sis. Of interest, the male-to-female ratio for multiple scle-
rosis is the highest in East Asia and gradually decreases as 
one moves west, which supports the hypothesis that early 
EBV infection predisposing East Asians to NPC could be 
related to a sex-linked recessive form of transmission [21].
HPV-positive OPC follows a reverse trend, with male 
Westerners exhibiting the highest incidences. The inci-
dences gradually decrease as one moves east. This result 
is a “perfect” mirror image of EBV-related NPC. On the 
other hand, although HPV-positive OPC is rare in East 
Asian females, 60% of these females who develop OPC 
are HPV-positive [22] (Table 1).
One potential explanation of why EBV and HPV are 
“complementary” but do not usually co-exist is that both 
EBV and HPV infections could conceivably persist in 
salivary gland tissues. Vestigial ectopic salivary gland tis-
sues can be found in human tonsils and tongue base [23], 
and this may account for the predilection of HPV-related 
cancers in these sites compared with other head and neck 
sites. Of note, EBV-related Eskimomas and other non-
NPC lymphoepitheliomas can also be found in other 
head and neck sites and the lungs.
Finally, the sexual revolution, which started just after 
the Second World War, puts the 1950s birth cohort at 
risk. If these individuals were to develop cancers 40 years 
later (after vertical transmission of HPV infection), HPV-
positive OPC would be expected to become evident only 
after the 1990s, which would fit into the epidemiological 
picture of this cancer.
Association between HPV‑positive OPC and HLA
A recent genome-wide association study (GWAS) [24] 
showed that “oropharyngeal cancer associations were 
limited to the human leukocyte antigen (HLA) region, 
and this association was considerably stronger in HPV-
positive cancers.” What is more intriguing is that HLA 
again appears to play an important and consistent role 
in several other virus-related cancers, such as NPC [25], 
extra-nodal natural killer T-cell lymphoma [26], EBV-
positive Hodgkin’s lymphoma [27], and chronic hepatitis 
B-associated hepatocellular carcinoma [28].
Non‑smoking East Asian female lung 
adenocarcinoma
Birth cohort
Interestingly, it was the 1950s birth cohort that exhibited 
a spike in female lung adenocarcinoma in Japan [29] and 
Hong Kong [30], and this pattern is intriguingly similar to 
that for HPV-positive OPC.
Associations between female lung adenocarcinoma 
and HPV
Anatharaman et  al. [31] observed a significantly 
increased risk of lung cancer in the presence of various 
HPV antibodies. Similar effects were observed for never, 
former, and current smokers. These results indicate that 
HPV antibodies are substantially increased in lung can-
cer patients compared with hospital-based controls, 
none of whom reported a previous cancer history or any 
tobacco-related disease. They subsequently reported that 
“although nearly 10% of the lung tumours were positive 
for any HPV DNA (7% for HPV16 DNA), none expressed 
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the viral oncogenes” [32]. It should however be noted 
that all these studies were performed in Europe.
On the other hand, an East Asian study showed a sig-
nificant increase in lung cancer risk amongst Taiwanese 
women with HPV infection [33]. An “adaptive” meta-
analysis also revealed a significant effect of HPV infection 
in lung cancer risk in East Asian women and never smok-
ers [34].
Associations between female lung adenocarcinoma 
and immune‑modulating factors
Associations are noted between lung adenocarcinoma 
and HLA [35], chronic rhinosinusitis [36, 37], and latent 
pulmonary tuberculosis [38]. In a Japanese study, “a 
decreased number of remaining teeth was associated with 
increased OR (odds ratio) of lung cancer [OR 1.54; 95% 
CI (confidence interval) 1.05–2.27; P trend = 0.027]” [39]. 
Two studies looking specifically at lung adenocarcino-
mas in Japanese also showed that HLA class II at 6p21.32 
was associated with epidermal growth factor receptor 
(EGFR) mutation-positive lung adenocarcinoma [40] 
and that major histocompatibility complex, class II, DM 
alpha (HLA-DMA) was overexpressed in female Japanese 
patients compared with male Japanese patients [41].
In sheep, the Jaagsiekte sheep retrovirus (JSRV), which 
can induce neoplastic transformation of the alveolar and 
bronchiolar secretory epithelial cells, is the cause of ovine 
pulmonary adenocarcinoma [42].
Triple‑negative breast carcinoma in East Asians
Associations between TNBC and HPV
Lawson et  al. [43] observed “the presence of high-risk 
HPV gene sequences in breast cancers; that HPV onco-
genic influences may occur early in the development of 
breast cancer; that HPVs in breast cancer are likely to 
be biologically active (as shown by transcription of HPV 
DNA to RNA plus the expression of HPV E7 proteins), 
and that there appeared to be a correlation between 
high-risk HPV in benign breast specimens and subse-
quent HPV-positive breast cancer in the same patient.” In 
another study, Subhawong et al. [44] showed that basal-
like breast carcinomas, which resemble HPV-associated 
squamous cell carcinomas morphologically, frequently 
exhibit a similar Rb−/p16+ phenotype. A study from Sin-
gapore showed a high prevalence of infection with high-
risk HPV in breast cancer patients [45]. A Mexican study 
detected high-risk HPV DNA in 8 (40.0%) of 20 meta-
plastic breast carcinomas [7 (87.5%) with HPV-16 infec-
tion and 1 (12.5%) with HPV-18 infection)] [46]. Another 
study from China, using paraffin-embedded breast can-
cer tissue samples, detected HPV18 E6 and HPV18 E7 in 
approximately 30% of the samples [47].
Table 1 Selected clinical characteristics of EBV and HPV infections across West Europe, East Europe, and East Asia
EBV Epstein–Barr virus, HPV human papilloma virus, OPC oropharyngeal carcinoma
Clinical characteristic West Europe East Europe East Asia
Early EBV infection + ++ ++++
Late EBV infection: infectious mononucleosis (IM) ++++ ++ +
 Male-to-female ratio (IM) 1:1.5 Not available Not available
Prevalence of (hypothesized late EBV infection) multiple sclerosis (MS) (per 105) >30 5–30 <5
 Male-to-female ratio (MS) 1:2 Not available 1:5
Hypothesized early infection with EBV in males + ++ ++++
Hypothesized early infection with EBV in females Rare + ++
Hypothesized early infection with HPV in males ++++ ++ +
Hypothesized early infection with HPV in females +++ ++ +++
Proportion of patients with HPV-positive OPC (%) 66 30 10
Proportion of female OPC patients who are HPV-positive (%) 45 40 60
Proportion of male OPC patients who are HPV-positive (%) 65 40 30
 Male-to-female ratio 1.5 1.0 0.5
Socio-economic status (1950s–1960s) ++++ ++ +
Associated chronic infections (e.g., chronic periodontitis and tuberculosis) + +++ ++++
Male HPV-positive OPC ++++ + Rare
Female nasopharyngeal carcinoma Rare + ++
Male nasopharyngeal carcinoma + ++ ++++
Female non-smoking lung adenocarcinoma + ++ ++++
Triple-negative breast cancer + ++ +++
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In a meta-analysis of case–controlled studies, HPV 
infection was found to have increased the risk of breast 
cancer [summary odds ratio (SOR) =  4.02, 95% CI 2.42–
6.68] [48]. In another meta-analysis, Li et al. [49] showed 
that 25% of the breast cancers were associated with HPV 
infection, of which approximately 30% occurred in Asia 
and 13% in Europe.
Recent studies also showed that “there were more cases 
with high expressions of HLA-G in non-luminal than in 
luminal subtypes (of breast cancer)” [50] and that “HLA 
expression was inversely correlated with oestrogen 
receptor (ER) expression in normal and cancerous breast 
tissue” [51].
Another study identified that the gene Lgr6, which 
labels progenitor cells, was associated with the luminal 
type of breast tumors [52]. One might be tempted to 
hypothesize that if a viral infection had hijacked the stem 
cell, the result might well be a non-luminal type of breast 
tumor. Intriguingly, two separate GWAS studies revealed 
that an Lgr6 single nucleotide polymorphism was associ-
ated with estrogen receptor (ER)-negative breast cancer 
[53], and the gene was also associated with TNBC [54]. It 
is also noteworthy that “the murine MMTV-Wnt1 model 
of mammary cancer shares transcriptional patterns with, 
and exhibits hallmarks of, human triple-negative breast 
cancer (TNBC)” [55].
Epidemiology of TNBCs
Younger women, who are diagnosed with breast can-
cer, appear to have more aggressive tumors and a 
higher incidence of poorly differentiated (grade III) 
and ER/progesterone receptor (PR)-negative cancers 
compared with older women. Interestingly, a study 
from Malaysia showed that TNBC appears to be asso-
ciated with a lower socio-economic status and that 
TNBC was most common in the native population of 
Sarawak (37%) and less frequent in Chinese (23%) and 
Malays (33%) [56]. Similar high incidences of TNBC 
were noted in the women of Northeast India [57] and 
Indonesia [58].
A recent study assessing breast cancer incidence trends 
in Japan [59] exhibited an increased incidence in young 
patients around the 1980s–1990s period, again reflect-
ing a similar pattern to both HPV-positive OPC and 
non-smoking East Asian female lung adenocarcinoma. A 
similar phenomenon was also observed in another study 
from Taiwan, China [60].
A study from Sweden reported an increased incidence 
of breast cancer within 15  years, amongst the women 
who were diagnosed with periodontal disease at an ini-
tial examination [61]. The average age of the women was 
46 years.
Summary and “epidemiological” model
Although no definite cause and association can be con-
cluded from the above, the circumstantial evidence sug-
gests the plausibility of the vertical transmission of HPV 
infection giving rise to HPV-positive OPC, non-smoking 
East Asian female lung adenocarcinoma, and East Asian 
TNBC (Table 1).
Clinical implications
The following two potential clinical implications can 
arise:
1. If HPV infection is a causative factor and is transmit-
ted vertically in the three types of cancers, there are 
potential applications in terms of
a. Prevention—using a HPV vaccination strategy 
applied during the perinatal period similar to that 
in the hepatitis B programme.
b. Targeted screening—for example, using HPV 
serology measured during the first month of life 
together with a susceptibility marker, such as “sus-
ceptible” HLA alleles.
2. The second observation is that the three types of can-
cers appear to be associated with
a. A favorable response to the new checkpoint 
inhibitors.
b. Some chronic infections/inflammation such as 
chronic periodontitis or chronic rhinosinusitis.
These findings might imply that the immune reaction 
associated with chronic infection might have a systemic 
bystander effect, namely affecting the body’s immune 
surveillance toward the pre-cancer, perhaps removing the 
immune suppressive effect, and thus allowing the cancer 
to grow [62]. It is conceivable that tackling chronic infec-
tion, such as chronic periodontitis, may reduce the inci-
dence of such cancers [63]. Studies have demonstrated 
that “subgingival scaling in patients with periodontitis 
reduced inflammatory markers” and that the regular use 
of aspirin may reduce the long-term risks of colorectal, 
esophageal, breast, and other cancers. Perhaps perio-
dontal disease should deserve a classification as a public 
health problem.
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